647-P: Outcomes Associated with the Medicare Diabetes Prevention Program
Introduction & Objective: The National Diabetes Prevention Program lifestyle change program (LCP) is an evidence-based behavior change intervention to prevent or delay type 2 diabetes among adults at high risk for type 2 diabetes. In 2018, the Centers for Medicare & Medicaid Services (CMS) b...
Gespeichert in:
Veröffentlicht in: | Diabetes (New York, N.Y.) N.Y.), 2024-06, Vol.73, p.1 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Introduction & Objective: The National Diabetes Prevention Program lifestyle change program (LCP) is an evidence-based behavior change intervention to prevent or delay type 2 diabetes among adults at high risk for type 2 diabetes. In 2018, the Centers for Medicare & Medicaid Services (CMS) began approving Centers for Disease Control and Prevention (CDC)-recognized organizations to deliver the Medicare Diabetes Prevention Program (MDPP) to eligible Medicare enrollees with prediabetes. Methods: This study compares outcomes for adults aged 65+ enrolled in the LCP in approved MDPP suppliers to those of adults aged 65+ enrolled in non-suppliers. The analysis used data submitted to CDC by organizations delivering the LCP from 23,579 participants who had the opportunity to complete the program on or before 08/31/2023 (n=2,324 MDPP; n=21,255 non-MDPP). Results: Among MDPP participants, 62.0% met the 5% programmatic weight loss goal, compared to 55.0% of non-MDPP participants (p |
---|---|
ISSN: | 0012-1797 1939-327X |
DOI: | 10.2337/db24-647-P |